CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,786,000 | +115.7% | 52,829 | +49.3% | 0.00% | +100.0% |
| Q1 2021 | $828,000 | -25.4% | 35,394 | -8.2% | 0.00% | -50.0% |
| Q4 2020 | $1,110,000 | +51.8% | 38,550 | +6.8% | 0.00% | +100.0% |
| Q3 2020 | $731,000 | -39.7% | 36,096 | -10.5% | 0.00% | -50.0% |
| Q2 2020 | $1,212,000 | +60.7% | 40,331 | +68.2% | 0.00% | 0.0% |
| Q1 2020 | $754,000 | -21.3% | 23,974 | +17.9% | 0.00% | 0.0% |
| Q4 2019 | $958,000 | +648.4% | 20,331 | +2.4% | 0.00% | – |
| Q3 2019 | $128,000 | -47.3% | 19,860 | +0.2% | 0.00% | – |
| Q2 2019 | $243,000 | +10.0% | 19,824 | +21.5% | 0.00% | – |
| Q1 2019 | $221,000 | – | 16,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |